Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Nature genetics, 2008•nature.com
Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here,
we show that iron deficiency anemia refractory to oral iron therapy can be caused by
germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease
produced by the liver that regulates the expression of the systemic iron regulatory hormone
hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron
homeostasis in humans.
we show that iron deficiency anemia refractory to oral iron therapy can be caused by
germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease
produced by the liver that regulates the expression of the systemic iron regulatory hormone
hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron
homeostasis in humans.
Abstract
Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron homeostasis in humans.
nature.com